Drug Shortage Report for APO-DAPAGLIFLOZIN
| Report ID | 267020 |
| Drug Identification Number | 02527197 |
| Brand name | APO-DAPAGLIFLOZIN |
| Common or Proper name | DAPAGLIFLOZIN |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DAPAGLIFLOZIN |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 BTL |
| ATC code | A10BK |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-09-09 |
| Estimated end date | 2025-11-28 |
| Actual end date | 2025-11-27 |
| Shortage status | Resolved |
| Updated date | 2025-11-28 |
| Company comments | 100 BTL available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2025-11-28 | English | Compare |
| v12 | 2025-11-27 | French | Compare |
| v11 | 2025-11-27 | English | Compare |
| v10 | 2025-11-06 | French | Compare |
| v9 | 2025-11-06 | English | Compare |
| v8 | 2025-10-16 | French | Compare |
| v7 | 2025-10-16 | English | Compare |
| v6 | 2025-10-10 | French | Compare |
| v5 | 2025-10-10 | English | Compare |
| v4 | 2025-09-25 | French | Compare |
| v3 | 2025-09-25 | English | Compare |
| v2 | 2025-09-11 | French | Compare |
| v1 | 2025-09-11 | English | Compare |
Showing 1 to 13 of 13